Plant omega-3s shouldn't be left out of the anti-inflammation story.
Published studies back omega-3 oils for lowering inflammation in humans, and flaxseed oil, a rich source of omega-3 alpha-linolenic acid (ALA), shouldn’t be left out of the story. A large-scale, multicenter study published in Nutrition Research offers the latest support behind flax oil for lowering inflammation.
Researchers from the Federal University of Rio Grande do Sul in Brazil recruited 160 adults undergoing hemodialysis therapy (which can induce inflammation) for kidney failure. Over 120 days, each subject was assigned to flax oil (1 g twice daily) or placebo (mineral oil twice daily) while receiving three dialysis units. 89 subjects (61%) were declared as having significant inflammation at the study’s baseline, as evidenced by C-reactive protein levels.
After three months of supplementation, 33% of flax oil subjects moved from an inflamed category to a not-inflamed category, compared to 16.9% of the placebo group. Reductions in C-reactive protein also correlated with reductions in body mass index and HDL cholesterol. The Brazilian study comes just months after the publication of another inflammation-related study in which hemodialysis patients who consumed flaxseed for eight weeks saw reductions in C-reactive protein, cholesterol, and triglyceride levels.
For all of your questions about flax-related research, check out the Flax Council of Canada's ongoing database of flax nutrition studies.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.